Key Points
- Jack Bendheim sold 7,040 shares on April 16 for $384,665.60 (avg $54.64) under a pre‑arranged Rule 10b5‑1 plan, reducing his stake to 117,000 shares (a 5.68% drop).
- The April sale is part of an ongoing program: Bendheim sold a total of 77,440 shares across multiple trades from February through April at prices mostly between $48.91 and $59.08.
- For context, Phibro recently beat quarterly EPS expectations and set FY2026 guidance of $2.93–3.10, with shares trading near $53.88 and a market capitalization of about $2.18 billion.
Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) CEO Jack Bendheim sold 7,040 shares of Phibro Animal Health stock in a transaction that occurred on Thursday, April 16th. The stock was sold at an average price of $54.64, for a total transaction of $384,665.60. Following the completion of the transaction, the chief executive officer directly owned 117,000 shares in the company, valued at approximately $6,392,880. This trade represents a 5.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jack Bendheim also recently made the following trade(s):
- On Tuesday, April 14th, Jack Bendheim sold 7,040 shares of Phibro Animal Health stock. The shares were sold at an average price of $59.08, for a total transaction of $415,923.20.
- On Thursday, March 19th, Jack Bendheim sold 7,040 shares of Phibro Animal Health stock. The stock was sold at an average price of $52.52, for a total transaction of $369,740.80.
- On Wednesday, March 18th, Jack Bendheim sold 10,560 shares of Phibro Animal Health stock. The stock was sold at an average price of $52.68, for a total transaction of $556,300.80.
- On Tuesday, March 17th, Jack Bendheim sold 5,280 shares of Phibro Animal Health stock. The shares were sold at an average price of $51.66, for a total transaction of $272,764.80.
- On Friday, March 13th, Jack Bendheim sold 5,280 shares of Phibro Animal Health stock. The shares were sold at an average price of $48.91, for a total value of $258,244.80.
- On Thursday, February 26th, Jack Bendheim sold 7,040 shares of Phibro Animal Health stock. The stock was sold at an average price of $53.73, for a total value of $378,259.20.
- On Tuesday, February 24th, Jack Bendheim sold 7,040 shares of Phibro Animal Health stock. The shares were sold at an average price of $51.37, for a total value of $361,644.80.
- On Friday, February 20th, Jack Bendheim sold 7,040 shares of Phibro Animal Health stock. The shares were sold at an average price of $51.42, for a total value of $361,996.80.
- On Wednesday, February 18th, Jack Bendheim sold 7,040 shares of Phibro Animal Health stock. The stock was sold at an average price of $51.40, for a total value of $361,856.00.
- On Friday, February 13th, Jack Bendheim sold 7,040 shares of Phibro Animal Health stock. The stock was sold at an average price of $51.96, for a total value of $365,798.40.
Phibro Animal Health Price Performance
Shares of PAHC opened at $53.88 on Friday. The business's 50-day moving average is $53.29 and its 200-day moving average is $44.96. The company has a debt-to-equity ratio of 2.14, a current ratio of 3.05 and a quick ratio of 1.22. The company has a market capitalization of $2.18 billion, a price-to-earnings ratio of 23.95, a P/E/G ratio of 0.84 and a beta of 0.69. Phibro Animal Health Corporation has a fifty-two week low of $16.16 and a fifty-two week high of $60.08.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $0.87 EPS for the quarter, topping the consensus estimate of $0.69 by $0.18. Phibro Animal Health had a net margin of 6.29% and a return on equity of 38.28%. The business had revenue of $373.91 million during the quarter, compared to analysts' expectations of $355.64 million. Phibro Animal Health has set its FY 2026 guidance at 2.930-3.100 EPS. Equities research analysts expect that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.
Phibro Animal Health Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Wednesday, March 25th. Stockholders of record on Wednesday, March 4th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 0.9%. The ex-dividend date was Wednesday, March 4th. Phibro Animal Health's payout ratio is currently 21.33%.
Institutional Investors Weigh In On Phibro Animal Health
Institutional investors and hedge funds have recently modified their holdings of the business. 1620 Investment Advisors Inc. boosted its holdings in Phibro Animal Health by 77.4% in the fourth quarter. 1620 Investment Advisors Inc. now owns 676 shares of the company's stock worth $25,000 after purchasing an additional 295 shares in the last quarter. Tudor Investment Corp ET AL lifted its position in shares of Phibro Animal Health by 3.4% in the third quarter. Tudor Investment Corp ET AL now owns 10,184 shares of the company's stock worth $412,000 after buying an additional 338 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in shares of Phibro Animal Health by 2.9% during the 2nd quarter. JPMorgan Chase & Co. now owns 13,005 shares of the company's stock worth $332,000 after acquiring an additional 363 shares in the last quarter. Farther Finance Advisors LLC increased its holdings in shares of Phibro Animal Health by 113.2% during the 4th quarter. Farther Finance Advisors LLC now owns 727 shares of the company's stock valued at $27,000 after acquiring an additional 386 shares during the last quarter. Finally, Brooklyn Investment Group increased its holdings in shares of Phibro Animal Health by 8.7% during the 4th quarter. Brooklyn Investment Group now owns 6,757 shares of the company's stock valued at $255,000 after acquiring an additional 538 shares during the last quarter. Institutional investors and hedge funds own 99.34% of the company's stock.
Wall Street Analysts Forecast Growth
PAHC has been the subject of several recent research reports. Citigroup initiated coverage on Phibro Animal Health in a report on Wednesday. They set a "neutral" rating and a $62.00 price objective for the company. Zacks Research raised Phibro Animal Health from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, March 11th. Weiss Ratings reaffirmed a "buy (b-)" rating on shares of Phibro Animal Health in a research note on Monday, December 29th. Finally, Morgan Stanley set a $49.00 price target on Phibro Animal Health in a report on Friday, February 6th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Phibro Animal Health presently has an average rating of "Hold" and an average price target of $42.40.
Get Our Latest Research Report on PAHC
About Phibro Animal Health
(
Get Free Report)
Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro's portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.
The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
